CD19 and malignant colon neoplasm: The authors revealed that CD19-28z CD8+ CAR-T cells with NR4A triple KO were capable of secreting IFNγ and TNFα upon restimulation and significantly prolonged the cells’ survival in melanoma and colon cancer mouse models expressing CD19.